NEW YORK (GenomeWeb News) - Keygene said today that it has purchased a 454 GS FLX sequencer from Roche and an Illumina Genome Analyzer.
The company upgraded to the GS FLX from a GS 20 and bought the Illumina hardware to "further develop its array of innovative DNA sequence-based applications," the company said today.
In early 2006, Keygene bought a GS 20 and a signed a co-marketing collaboration with Roche to market plant genetics applications it developed using the 454 sequencer.
The company said it will use the higher-throughput GS FLX to serve its customers' sequencing needs and to support its internal mutation screening and polymorphisms discovery applications.
Keygene said it will use the Illumina analyzer for transcript mapping and for developing applications such as its Amplified Fragment Length Polymorphism method for whole-genome mapping.
Financial terms of the deals were not released.